The inside story of CSX’s CEO shakeup

A dispute over pay and a botched informal outreach from a rival led to Joe Hinrichs’ board losing confidence in his ability ...

Up 22% in 3 months! Should investors consider buying shares in this FTSE 100 pharma giant?

Shares in FTSE 100 giant AstraZeneca (LSE:AZN) are up 22% in three months, but is it a good time to buy? The post Up 22% in 3 months! Should investors consider buying shares in this FTSE 100 pharma ...
Zacks Investment Research on MSN

Here's Why GSK (GSK) is a Strong Momentum Stock

It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different ...

While there are bubbles in the stock market, this sector looks dirt cheap

There’s a lot of froth in the stock market right now. Yet at the same time, there are also a lot of bargains for long-term investors. The post While there are bubbles in the stock market, this sector ...

Here's Why GSK (GSK) is a Strong Value Stock

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.